Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Glioblastoma (GBM) is the most common primary brain tumor. Despite aggressive treatment, GBM almost always recurs. The current standard-of-care for treatment of newly diagnosed GBM has remained relatively unchanged since 2005: maximal safe resection followed by concomitant chemoradiation (CRT) with...
Main Authors: | Denise Fabian, Maria del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, Nikhil Sebastian, Pierre Giglio, Vinay Puduvalli, Javier Gonzalez, Joshua D. Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/174 |
Similar Items
-
Enhancing glioblastoma treatment through the integration of tumor-treating fields
by: Katarzyna Szklener, et al.
Published: (2023-10-01) -
Tumor treating fields: a new treatment for glioblastoma
by: Dimitar Slavkov, et al.
Published: (2023-12-01) -
The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
by: Aleksandrs Krigers, et al.
Published: (2022-06-01) -
Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
by: Josef Vymazal, et al.
Published: (2023-01-01) -
Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
by: Sumit Mukherjee, et al.
Published: (2018-07-01)